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Abstract
The authors report a case of a patient with isolated synchronous splenic metastasis from
obstructing colon cancer. A 43 years old Thai female presented with abdominal distension and
obstipation. CT scan of whole abdomen demonstrated a mass located at the splenic flexure and an
isodense mass at the superior pole of the spleen, which was considered to be an isolated splenic
metastasis. With the presumptive diagnosis of obstructing colon cancer at splenic flexure with isolated
splenic metastasis. The patient underwent total colectomy with ileorectal anastomosis concomitant
with splenectomy. These procedures are a successful curative option and safe for the management of
this condition. Adjuvant chemotherapy following the operation to achieve long term survival and long
term follow-up with monitoring of serum CEA levels, CT scan of abdomen and colonoscopy are neces-
sary for long-term follow-up.
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Case report
A 43 years old Thai female presented
with abdominal distension and obstipation for 1
week. Physical examination revealed hyperactive
bowel sounds and abdominal distension. No
hepato-splenomegaly was detected.  Films of
acute abdomen series showed the dilatation of
the small bowel and large bowel through the level
of splenic flexure and no pulmonary metastasis
was detected on the chest radiograph. A
computed tomography scan (CT scan) of the whole
abdomen demonstrated an irregularpolyploid
tumor mass located at the splenic flexure
with an isodense mass size of 2.6 x 1.6 cm at
the superior pole of the spleen. No evidence
of hepatic and peritoneal metastasis was
demonstrated.
Laboratory tests were performed and
showed the serum carcinoembryonic antigen
(CEA) level of 9.7 ng/ml (normal range < 4 ng/
ml). With a presumptive diagnosis of obstructing
colon cancer at the splenic flexure with isolated
splenic metastasis, the patient underwent an
operation.
On explorative laparotomy, the large
bowel was distended and the cecum diameter
was about 8 cm. A 4.5 cm. tumor mass was
located at the splenic flexure causing nearly
complete luminal obstruction. The splenic size
was 7.5?4.5?3.2 cm and weighted 50 grams.
There was palpable mass at superior pole of the
Figure 1:  CT scan of abdomen showing tumor at splenic flexure (A) and solid mass at
superior   pole of spleen (B)
spleen measured 4 x 2.7 x 2.3 cm but inferior
pole of the spleen was intact.  No hepatic
metastasis was detected by intraoperative
ultrasonography  (IOUS) .  Neither intraperitoneal
seeding of the tumor, lymph node metastasis
nor ascites were found. A total colectomy with
side-to-end ileorectal anastomosis was performed
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by hand sewn technique concomitant with
splenectomy  as a curative procedure that is in
trend. Operative time was 200 minutes and the
estimated blood loss was about 150 ml.
Pathologic study of the resected
specimen showed moderately differentiated
adenocarcinoma invasion through the muscular
layers into pericolic tissue, and metastasis was
found in 5 of the 16 pericolic lymph nodes.
Histological ly, the splenic lesion was a
metastasized adenocarcinoma from colon cancer
(T3 N2 M1).
The postoperative course was unevent-
ful.  Adjuvant chemotherapy (FOLFOX 4 regimen)
was started on the fourteenth postoperative day.
After the seventh month of the follow-up period
neither recurrent tumors nor other systemic
metastasis were detected.
Discussion
The incidence of isolated synchronous
splenic metastasis from colorectal cancer is low.
Figure 2: Demonstration of the tumor at the splenic flexure(A) and the upper pole of the
spleen(B)
Only 13 cases have been reported in English
literature, indicating a sign of extensive
disease.   This can be rationalized by the
following theories:
1. Colorectal cancer cells could not reach the
spleen through the usual portal venous sys-
tem from the spleen to the liver,
2. The sharp angulation of the splenic artery
with the celiac axis and the rhythmic
contractions of the sinusoidal splenic
architecture limits the metastasis.
3. The spleen is the second largest organ of
the reticuloendothelial system, and immune
substances such as çsplenic factoré appear
to inhibit tumor cell proliferation and destroy
tumor cells   However, splenic metastasis
could be explained by retrograde spread of
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colorectal cancer cells from the inferior
mesenteric vein to the splenic vein . Since
most patients are asymptomatic. Diagnosis
of isolated splenic metastasis can be made
preoperatively by imaging studies and
raising serum CEA levels.
Long-term survival after splenectomy in
the patients with isolated metachronous splenic
metastasis from colon carcinoma varies from 0.5
to 7 years  , but survival in patients with isolated
synchronous splenic metastasis is still unknown.
Many of literatures suggest splenectomy followed
by adjuvant chemotherapy were improvement
of long-term survival for patients.
In this case we performed a total
colectomy with ileorectal anastomosis concomi-
tant with splenectomy, which is a safe and
curative surgical procedure. The patient receiving
adjuvant chemotherapy (FOLFOX 4 regimen) in
postoperative period. Long-term follow-up with
monitoring of serum CEA levels, CT scan of the
abdomen, and colonoscopy are necessary as is
true for other colorectal cancer patients, for
surveillance of local tumor recurrent and systemic
metastasis.
Conclusion
Isolated synchronous splenic metastasis
in colorectal cancer with obstruction is rare. No
long-term follow up data and long-term survival
of the patient has been reported. Total colec-
tomy concomitant with splenectomy as a safe
curative procedure for the management of this
condition and the patient must receive adjuvant
chemotherapy following the operation to achieve
long-term survival.
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